Search Results - Meilinger-Dobra, Mónika

  • Showing 1 - 2 results of 2
Refine Results
  1. 1
    EGFR R521K Polymorphism Is Not a Major Determinant of Clinical Cetuximab Resistance in Head and Neck Cancer

    EGFR R521K Polymorphism Is Not a Major Determinant of Clinical Cetuximab Resistance in Head and Neck Cancer by Cserepes, Mihály, Nelhűbel, Györgyi A, Meilinger-Dobra, Mónika, Herczeg, Adrienn, Türk, Dóra, Hegedűs, Zita, Svajda, Laura, Rásó, Erzsébet, Ladányi, Andrea, Csikó, Kristóf György, Kenessey, István, Szöőr, Árpád, Vereb, György, Remenár, Éva, Tóvári, József

    Published in Cancers
    Get full text
    Items that this one cites
    Items that cite this one
    Article
    Save to List
    Saved in:
  2. 2
    Abstract 1863: Correlations of genetic variation R521K of EGF receptor and the in vitro, in vivo and clinical phenotypes of head and neck cancers after cetuximab treatment

    Abstract 1863: Correlations of genetic variation R521K of EGF receptor and the in vitro, in vivo and clinical phenotypes of head and neck cancers after cetuximab treatment by Cserepes, Mihaly T., Hegedus, Zita, Ranđelović, Ivan, Kenessey, Istvan, Meilinger-Dobra, Mónika, Csikó, Kristóf G., Ladanyi, Andrea, Remenár, Éva, Tovari, Jozsef

    Get full text
    Article
    Save to List
    Saved in:

Search Tools: